A kind of imazalil hapten ym-a, artificial antigen, heavy chain antibody and its preparation method and application
A technology of YM-A and artificial antigen, which is applied in the biological field to achieve the effect of simple preparation method, strong specificity and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] The preparation of embodiment 1 imazalil hapten YM-A
[0049] A preparation method of imazalil hapten YM-A, comprising the following steps:
[0050] Dissolve 1mol imazalil in 50mL dioxane solution, add 0.5mol KMnO 4and NaIO4 under magnetic stirring at 20°C for oxidation reaction, after reflux for 4h, the reactants were layered, the organic layer was distilled under reduced pressure to remove the solvent, and the concentrate was purified by silica gel column chromatography to obtain the reaction product A; 100mg of the reaction product A Add 75 mg of carboxymethylhydroxylamine hemihydrochloride and carry out oximation condensation derivatization reaction under magnetic stirring in an oil bath at 60°C. After reflux overnight (24h), the reaction product is extracted with ethyl acetate and saturated NaCl, and the liquid-liquid layer is separated. After the filtrate was distilled under reduced pressure to remove the solvent, the organic phase was dried and concentrated, and...
Embodiment 2
[0052] The preparation of embodiment 2 imazalil artificial antigen
[0053] 1. Experimental method
[0054] A preparation method of imazalil artificial antigen, comprising the following steps:
[0055] The imazalil hapten YM-A prepared in Example 1 was coupled to ovalbumin OVA (albumin) and lactoferrin LF (lactoferrin) by the active ester method, and the imazalil hapten YM-A was dissolved in DMF Add 1.5eq NHS and EDC to the solution and react overnight at 4°C, which is recorded as solution A; add solution A dropwise to the PBS buffer solution of the carrier protein, and continue to react at 4°C for 8 hours; Dialyze at ℃ for 3 days, change the dialysate twice a day, dialyze 6 times in total, collect the solution (immunogen solution) in the dialysis bag, and obtain the imazalil artificial antigen (imazalil complete antigen YM-A-LF and inhibitory imazalil complete antigen YM-A-OVA), and utilize the ultraviolet spectrophotometer to the imazalil hapten YM-A that embodiment 1 prep...
Embodiment 3
[0059] The identification of embodiment 3 imazalil artificial antigen
[0060] 1. Experimental method
[0061] Healthy alpacas were used as experimental animals, and the imazalil complete antigen YM-A-LF prepared in Example 2 was used as the immunogen, and subcutaneously injected into the back and neck of the alpaca, and each immunization dose was 0.5 mL (which contained 0.5 mg immunogen). For the first immunization, 0.5 mL of complete Freund's adjuvant was emulsified with antigen for immunization, and 4 weeks later, 0.5 mL of incomplete Freund's adjuvant was used for booster immunization after emulsification with antigen, and then booster immunization was performed every 2 weeks. Before immunization, 10 mL of blood-separated serum was used as a negative control. From the second immunization, 10mL of blood was taken one week after each immunization for serum titer and competition reaction detection to determine whether the imazalil complete antigen YM-A-LF is immunogenic.
...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


